ClinicalTrials.gg
Sign In

Prostatic Diseases clinical trials

The registry lists 84 studies for Prostatic Diseases across more than 10 countries. 19 are recruiting or about to start. 14 of them are mainly about Prostatic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 4 narrower conditions too, such as Prostatic Neoplasms: 7,966 studies, 1,767 open.

Get an email when these change. Save the Prostatic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Recruiting
17
Status unknown
9
Terminated
7
Active, not recruiting
6
Withdrawn
4

Phase

Phase 2
21
Phase 1
20
Phase 3
7
Phase 4
4

Where

United States
38
United Kingdom
9
France
9
Canada
6
Spain
5
Italy
5

Who runs them

Steba Biotech S.A. (6) · Beth Israel Deaconess Medical Center (2) · University of Rochester (2) · H. Lee Moffitt Cancer Center and Research Institute (2) · Antev Ltd. (2) · Rigshospitalet, Denmark (2) · Advanced Accelerator Applications (2) · Sanofi (2)

What is being tested here

Drugs under test in Prostatic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Darolutamide202
Lutetium (¹⁷⁷Lu) vipivotide tetraxetan112
Enzalutamide101
Talazoparib101
Lutetium Lu 177 Ludotadipep111
Lutetium-177101
Gedatolisib101
Padeliporfin025
Nivolumab002
Alfuzosin002

Drug classes tested here Antiandrogens 3 open

Coming up

2phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 17 Prostatic Diseases studies recruiting now, 13 (76%) set no upper age limit and 1 (6%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 17 (100%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
100 (0%)0 (0%)
180 (0%)13 (76%)
300 (0%)14 (82%)
400 (0%)15 (88%)
500 (0%)16 (94%)
650 (0%)17 (100%)
750 (0%)16 (94%)
850 (0%)15 (88%)

Across all 84 studies, recruiting or not: 8% stop at 75 or younger and 2% at 65; 11% take children; 0% are for women only and 92% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Prostatic Diseases studies take

Of 21 interventional studies with no phase under Prostatic Diseases, half reached primary completion within 54 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase54 mo18–81 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 → or search them.